BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1213648)

  • 1. Prolonged suppression of insulin release by insulin-induced hypoglycemia: demonstration by C-peptide assay.
    Horwitz DL; Rubenstein AH; Reynolds C; Molnar GD; Yanaihara N
    Horm Metab Res; 1975 Nov; 7(6):449-52. PubMed ID: 1213648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
    Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
    Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.
    Horwitz DL; Starr JI; Mako ME; Blackard WG; Rubenstein AH
    J Clin Invest; 1975 Jun; 55(6):1278-83. PubMed ID: 1133173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin, proinsulin and c-peptide in serum of induced hypoglycemia].
    Beischer W; Keller L; Schürmeyer E; Raptis S; Thum C; Pfeiffer EF
    Verh Dtsch Ges Inn Med; 1975; 81():1493-5. PubMed ID: 1227005
    [No Abstract]   [Full Text] [Related]  

  • 6. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS; Ho LT
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human proinsulin: bioactivity and pharmaco-kinetics after intravenous and subcutaneous administration.
    Schatz H; Ammermann S
    Horm Metab Res Suppl; 1988; 18():1-5. PubMed ID: 3056805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
    Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
    Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis of insulinomas and other causes of fasting hypoglycemia.
    Turner RC
    Horm Metab Res; 1976; Suppl 6():40-5. PubMed ID: 179928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma glucose, insulin, proinsulin, C-peptide and glucagon before and after a carbohydrate-rich meal in hyperthyroid patients.
    Rovira A; Valdivielso L; Ortega R; Valverde I; Herrera Pombo JL
    Diabete Metab; 1987; 13(4):431-5. PubMed ID: 3315763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
    Rosak C; Hofmann U; Paulwitz O
    Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivity and pharmacokinetics of human proinsulin in comparison to human insulin after intravenous and subcutaneous injection.
    Schatz H; Ammermann S; Laube H; Federlin K
    Horm Metab Res; 1988 Jul; 20(7):445-9. PubMed ID: 3049293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-peptide suppression test for insulinoma.
    Service FJ; Horwitz DL; Rubenstein AH; Kuzuya H; Mako ME; Reynolds C; Molnar GD
    J Lab Clin Med; 1977 Jul; 90(1):180-6. PubMed ID: 194989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secretion of c-peptide and its changes in the blood--introduction].
    Horino M; Oyama H
    Horumon To Rinsho; 1977 Oct; 25(10):1059-65. PubMed ID: 338208
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypoglycemia induced by insulin antibody during postoperative management with intravenous hyperalimentation--a case report and qualitative analysis of insulin antibody].
    Yasuda T; Ishikawa O; Ohigashi H; Furukawa H; Imaoka S; Iwanaga T; Sasakuma F
    Nihon Geka Gakkai Zasshi; 1989 Jun; 90(6):949-52. PubMed ID: 2507901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic ketoacidosis: evidence for C-peptide and proinsulin secretion following recovery.
    Block MB; Mako ME; Steiner DF; Rubenstein AH
    J Clin Endocrinol Metab; 1972 Sep; 35(3):402-6. PubMed ID: 4626271
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas.
    Turner RC; Heding LG
    Diabetologia; 1977 Dec; 13(6):571-7. PubMed ID: 201531
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-insulin antibodies are a cause of hypoglycemia following pancreas transplantation.
    Tran MP; Larsen JL; Duckworth WC; Ruby EI; Miller SA; Frisbie K; Taylor RJ; Stratta RJ
    Diabetes Care; 1994 Sep; 17(9):988-93. PubMed ID: 7988320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperproinsulinemia in hypoglycemic subjects.
    Duckworth WC; Kitabchi AE
    Horm Metab Res; 1972 May; 4(3):133-5. PubMed ID: 5065149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.